Home/Filings/4/0001493152-25-001727
4//SEC Filing

Gleason Shane Thomas 4

Accession 0001493152-25-001727

CIK 0001433607other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 4:30 PM ET

Size

7.6 KB

Accession

0001493152-25-001727

Insider Transaction Report

Form 4
Period: 2025-01-07
Gleason Shane Thomas
Chief Commercial Officer
Transactions
  • Award

    Options to purchase common stock (right to buy)

    2025-01-07+106,218289,346 total
    Exercise: $2.71Exp: 2035-01-07Common Stock (106,218 underlying)
  • Award

    Common Stock

    2025-01-07+232,616746,981 total
Footnotes (2)
  • [F1]These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.
  • [F2]The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

Documents

1 file

Issuer

InspireMD, Inc.

CIK 0001433607

Entity typeother

Related Parties

1
  • filerCIK 0001966214

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:30 PM ET
Size
7.6 KB